These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2454614)

  • 1. [Advances in the comprehensive treatment of ovarian cancer].
    Yakushiji M; Sugiyama T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1855-62. PubMed ID: 2454614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of ovarian cancer].
    Kato T; Nishimura H
    Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radical surgery for ovarian cancer].
    Ochiai K; Takakura S; Kawashima M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1977-81. PubMed ID: 1417006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer.
    Lawton FG; Redman CW; Luesley DM; Chan KK; Blackledge G
    Obstet Gynecol; 1989 Jan; 73(1):61-5. PubMed ID: 2462202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies of second-look operations (SLO) in ovarian cancer].
    Yuzawa H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1310-6. PubMed ID: 2658822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of the second-look operation in ovarian cancer.
    Schwartz PE
    Clin Obstet Gynaecol; 1983 Aug; 10(2):245-59. PubMed ID: 6193920
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in CA125 concentration in ovarian cancer patients during the remission state--mean attenuating curve and the effectiveness of surgery and chemotherapy].
    Kawai M; Inagaki S; Yamashita H; Imaizumi H; Kakihara M; Arii Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):537-42. PubMed ID: 2474041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide].
    Huang H; Lian L; Huang R
    Zhonghua Fu Chan Ke Za Zhi; 1995 May; 30(5):265-9. PubMed ID: 7544256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment and overview for the improvement of prognosis in ovarian cancer].
    Terashima Y; Ochiai K; Sasaki H; Yokoyama S; Murae M; Niimi S
    Gan No Rinsho; 1990 Aug; 36(10):1199-205. PubMed ID: 2214160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early diagnosis and effective treatment of ovarian cancer].
    Sawada M; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1983 May; 10(5):1251-8. PubMed ID: 6191676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of malignant germ cell tumor of the ovary.
    Aziz MF
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of ovarian endodermal sinus tumor.
    Lian L; Huang H; Huang R; Lang J
    Chin Med J (Engl); 1996 May; 109(5):344-8. PubMed ID: 9208488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of malignant ovarian germ cell tumor and sex cord tumors].
    Sugiyama T; Ohta S; Tomonari R; Kamura T
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1358-62. PubMed ID: 12214461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
    Li M; Huang X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):621-3. PubMed ID: 9275460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and fetal survival following surgery and chemotherapy of endodermal sinus tumor of the ovary during pregnancy: a case report.
    Kim DS; Park MI
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):503-7. PubMed ID: 2464778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
    Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.